Results 11 to 20 of about 45,501 (263)

The significance of Fas, tumor necrosis factor-related apoptosis-inducing ligand and fibrinolytic factors in the assessment of malignant pleural effusion [PDF]

Archives of Biological Sciences, 2022
Few studies have examined the usefulness of soluble apoptotic markers for the screening of pleural effusion. This study aimed to investigate the significance of Fas, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and fibrinolytic factors
Choi Jong Weon, Lee Moon Hee, Fujii Tatsuyoshi   +2 more
doaj   +1 more source

Diagnostic value of SHOX2, RASSF1A gene methylation combined with CEA level detection in malignant pleural effusion

BMC Pulmonary Medicine, 2023
Aim To investigate the diagnostic value of combined detection of SHOX2 and RASSF1A gene methylation with carcinoembryonic antigen (CEA) level in diagnosing malignant pleural effusion.
Shaosen Chen, Kunlun Huang, Lin Zou, Lu Chen, Peicun Hu   +4 more
doaj   +1 more source

Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion

Thoracic Cancer, 2020
Malignant tumors are often associated with eosinophilic pleural effusion. Here, we encountered a case of interleukin‐5 (IL‐5)‐producing malignant pleural mesothelioma with eosinophilic pleural effusion. The patient was a 50‐year‐old male.
Eiji Takeuchi, Naoki Takahashi, Shun Morizumi, Hiroyuki Tamiya, Hisashi Matsuoka, Naoto Kuroda, Kenji Yorita   +6 more
doaj   +1 more source

Pleural Fluid Resolution Is Associated with Improved Survival in Patients with Malignant Pleural Effusion

Life, 2023
Malignant pleural effusion is associated with a poor prognosis and, while risk stratification models exist, prior studies have not evaluated pleural fluid resolution and its association with survival.
Christina R. MacRosty, Amber Wright, Agathe Ceppe, Sohini Ghosh, A. Cole Burks, Jason A. Akulian   +5 more
doaj   +1 more source

Differential diagnosis between benign and malignant pleural effusion with dual-energy spectral CT. [PDF]

PLoS ONE, 2018
To investigate the value of spectral CT in the differential diagnosis of benign from malignant pleural effusion.14 patients with benign pleural effusion and 15 patients with malignant pleural effusion underwent non-contrast spectral CT imaging.
Xirong Zhang, Haifeng Duan, Yong Yu, Chunling Ma, Zhanli Ren, Yuxin Lei, Taiping He, Ming Zhang   +7 more
doaj   +1 more source

New biomarkers for the diagnosis of pleural effusion

The Egyptian Journal of Bronchology, 2022
Background Persistent undiagnosed effusion is present in approximately 15% of all causes of exudative effusion. Pleural effusion caused by immunoglobulin G4 (IgG4) is a new type of pleural effusion.
Raafat T. El-Sokkary, Nermen M. Abuelkassem, Mohamed Ismail Seddik, Ahmed Metwally   +3 more
doaj   +1 more source

Diagnostic value of procalcitonin and C-reactive protein in differentiation between some benign and malignant pleural

Egyptian Journal of Chest Disease and Tuberculosis, 2014
Pleural effusion is relatively common clinical condition that requires differential diagnosis. It is defined as collection of fluid in pleural space. Pleural effusion is often diagnostic dilemma for the physician.
Wafaa S. El-Shimy, Ghada A. Attia, Sahar M. Hazzaa, Yousef M. Mansour, Walaa M. Abd El-Halim   +4 more
doaj   +1 more source

A clinical study of pleural effusion and its radiological, biochemical, bacteriological and cytological correlation

Journal of Integrated Health Sciences, 2017
Introduction: Pleural effusion refers to excessive or abnormal accumulation of fluid in the pleural space. It is a commonly encountered medical problem caused by a variety of underlying pathological conditions.
N D Khamar, P R Gohil, R N Thacker, U S Gediya   +3 more
doaj   +1 more source

Different Therapeutic Strategies in 2 Young Patients with Advanced ALK-Rearranged Lung Adenocarcinoma: “The Light at the End of the Tunnel”

Case Reports in Oncology, 2021
Malignant pleural effusion represents a prognostic negative factor on survival conferring stage IV disease. The median of survival is 5 months and a 5-year survival of about 3%.
Umberto Caterino, Cristiano Cesaro, Enzo Zamparelli, Flavio Cesaro, Alba Palma, Raffaella Lucci, Pasquale Imitazione, Dino Casazza, Dario Amore   +8 more
doaj   +1 more source

C-reactive protein and serum amyloid A levels in discriminating malignant from non-malignant pleural effusion

Egyptian Journal of Chest Disease and Tuberculosis, 2015
Introduction: Distinction between malignant and non-malignant pleural effusion is of great importance in the patient management. The aim: We examined the diagnostic value of C-reactive protein (CRP) and serum amyloid A (SAA) in distinguishing different ...
Hala Mohamed Shalaby Samaha, Amany Ragab Elsaid, Rasha Elzehery, Rania Elhelaly   +3 more
doaj   +1 more source